venBio Partners LLC
- SEC CIK
- 0001776382
- Latest filing
- Aug 14, 2026
Holdings in Q1 2021
Holdings as of Mar 31, 2021, filed May 17, 2021. Long positions only.
- Positions
- 8
- No 13F data for Q4 2020
- Portfolio value
- $1.05B
- No 13F data for Q4 2020
Livermore's 13F data starts with Q1 2021, so this quarter has no previous quarter to compare with and changes are not shown.
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| ALXOAlx Oncology Holdings Inc | COM | 9,699,925 | $715.3M | 68.0% | – | – | History |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 3,504,624 | $115.8M | 11.0% | – | – | History |
| AKROAkero Therapeutics, Inc. | COM | 2,444,311 | $70.9M | 6.7% | – | – | History |
| PHVSPharvaris N.V. | COM | 2,303,310 | $64.4M | 6.1% | – | – | History |
| CMPICheckmate Pharmaceuticals, Inc. | COM | 3,673,374 | $44.6M | 4.2% | – | – | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 490,471 | $21.0M | 2.0% | – | – | History |
| MTCRMetacrine, Inc. | COM | 3,059,123 | $19.0M | 1.8% | – | – | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 161,897 | $1.35M | 0.1% | – | – | History |